Clinical Trial Update: PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

View source ↗

Summary

A completed trial reports the pharmacokinetics of a once-daily antiretroviral regimen containing tenofovir and atazanavir/ritonavir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• REYATAZ (atazanavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV Infections | Status: COMPLETED